serena williams which glp 1 reveals she's been taking a GLP-1 medication to help her with weight loss, and she's down 31 pounds. She's launching a campaign with the health care company Ro to normalize Serena's on Ro - YouTube

Depot effect at the injection site : The fatty acid moiety promotes self-association and interaction with subcutaneous tissue components at the injection site, creating a slow-release depot that contributes to sustained absorption after subcutaneous administration

Healthcare facility capacity development in obesity management creates infrastructure for comprehensive patient care delivery

WeightWatchers now includes access to the Wegovy pill, giving members an oral alternative to injections

In December 2025, Eli Lilly announced $3 billion expansion of its Wisconsin facility to meet surging demand for GLP-1 drugs like Zepbound and Mounjaro

Consumer demand can accelerate production or shipment priorities

Constipation and diarrhea, as well as some abdominal discomfort and bloating, are other G.I